Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1
Keyword(s):
2015 ◽
Vol 15
(12)
◽
pp. 1389-1403
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
1975 ◽
Vol 16
(2)
◽
pp. 275-283
◽
Keyword(s):